{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:37:24Z","timestamp":1793320644957,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.pharmthera.2020.107788","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T01:25:36Z","timestamp":1607995536000},"page":"107788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency"],"prefix":"10.1016","volume":"222","author":[{"given":"Kaitlyn","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107788_bb0005","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood.V96.7.2358","article-title":"Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a west African population with a low prevalence of hemoglobin S","volume":"96","author":"Agarwal","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0010","author":"Alabama"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s13104-018-3964-7","article-title":"Spectrophotometry assays to determine G6PD activity from trinity biotech and pointe scientific G6PD show good correlation","volume":"11","author":"Alam","year":"2018","journal-title":"BMC Research Notes"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206331","article-title":"Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Alam","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s10038-019-0700-7","article-title":"Genotyping of Malaysian G6PD-deficient neonates by reverse dot blot flow-through hybridisation","volume":"65","author":"Alina","year":"2020","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0030","author":"Allergy, N. I. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0035","author":"Allergy, N. I. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ijlh.12943","article-title":"Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency","volume":"41","author":"Anantasomboon","year":"2019","journal-title":"International Journal of Laboratory Hematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/20477724.2020.1751388","article-title":"Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?","volume":"114","author":"Aydemir","year":"2020","journal-title":"Pathogens and Global Health"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0050","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1182\/blood-2003-11-3820","article-title":"Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait","volume":"104","author":"Ayi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0260106019885290","article-title":"Probable blueberry-induced haemolysis in a G6PD deficient child: A case report","volume":"25","author":"Babu","year":"2019","journal-title":"Nutrition and Health"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4269\/ajtmh.14-0696","article-title":"Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests","volume":"92","author":"Bancone","year":"2015","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107788_bb5000","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1172\/JCI107943","article-title":"The postnatal decline of hemoglobin F synthesis in normal full-term infants","volume":"55","author":"Bard","year":"1975","journal-title":"J Clin Invest."},{"key":"10.1016\/j.pharmthera.2020.107788_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190272","article-title":"Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials","volume":"13","author":"Bastiaens","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2146\/ajhp160961","article-title":"Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency","volume":"75","author":"Belfield","year":"2018","journal-title":"American Journal of Health-System Pharmacy"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0075","doi-asserted-by":"crossref","first-page":"7970463","DOI":"10.1155\/2018\/7970463","article-title":"Isolation, molecular characterization and probiotic potential of lactic acid bacteria in Saudi raw and fermented Milk","volume":"2018","author":"Bin Masalam","year":"2018","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/clpt.1983.54","article-title":"Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency","volume":"33","author":"Bloom","year":"1983","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0085","series-title":"Caring for Glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: Implications for pharmacy. P T","first-page":"572","volume":"40","author":"Bubp","year":"2015"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0090","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/AAC.01948-15","article-title":"In vitro activities of Primaquine-Schizonticide combinations on asexual blood stages and gametocytes of plasmodium falciparum","volume":"59","author":"Cabrera","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001557","article-title":"Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency","volume":"3","author":"Chao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0105","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/jiy014","article-title":"Safety of single-dose Primaquine in G6PD-deficient and G6PD-normal males in Mali without malaria: An open-label, phase 1, dose-adjustment trial","volume":"217","author":"Chen","year":"2018","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","article-title":"NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism","volume":"1","author":"Chen","year":"2019","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cca.2019.04.074","article-title":"Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program","volume":"495","author":"Chiu","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","article-title":"Primaquine-induced haemolysis in females heterozygous for G6PD deficiency","volume":"17","author":"Chu","year":"2018","journal-title":"Malaria Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107788_bb0125","first-page":"663","article-title":"A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants","volume":"49","year":"2011","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0130","author":"Consortium, M"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12936-019-2950-4","article-title":"Pharmacokinetics\/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine","volume":"18","author":"Daher","year":"2019","journal-title":"Malaria Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220977","article-title":"Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in plasmodium vivax malaria endemic setting in Mauritania","volume":"14","author":"Djigo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0145","first-page":"1069","article-title":"Inverse association between Glucose6Phosphate dehydrogenase deficiency and hepatocellular carcinoma","volume":"19","author":"Dore","year":"2018","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0150","author":"Dourado, F. D. M. T. D. H. V"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017371","article-title":"Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia","volume":"6","author":"Dunyo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12879-019-3862-1","article-title":"The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians","volume":"19","author":"Dysoley","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0165","article-title":"G6PD deficiency prevalence as a cause of neonatal jaundice in a neonatal Ward in Dohuk, Iraq","author":"Eissa","year":"2019","journal-title":"American Journal of Perinatology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0170","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.02889-14","article-title":"Glucose-6-phosphate dehydrogenase status and risk of hemolysis in plasmodium falciparum-infected African children receiving single-dose primaquine","volume":"58","author":"Eziefula","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2012.01.015","article-title":"Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway","volume":"294","author":"Ganesan","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jat.1493","article-title":"Cytochrome P450-dependent toxicity of dapsone in human erythrocytes","volume":"30","author":"Ganesan","year":"2010","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2009.07.012","article-title":"Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes","volume":"241","author":"Ganesan","year":"2009","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.fct.2013.01.055","article-title":"Alpha-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency","volume":"61","author":"Georgakouli","year":"2013","journal-title":"Food and Chemical Toxicology"},{"issue":"18","key":"10.1016\/j.pharmthera.2020.107788_bb0195","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1158\/0008-5472.CAN-19-2486","article-title":"Glucose-6-phosphate dehydrogenase is not essential for K-Ras-driven tumor growth or metastasis","volume":"80","author":"Ghergurovich","year":"2020","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0200","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/cid\/ciy235","article-title":"Primaquine pharmacokinetics in lactating women and breastfed infant exposures","volume":"67","author":"Gilder","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107788_bb0205","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ajh.25941","article-title":"CYB5R3(c) (.350C>G) and G6PD A alleles modify severity of Anemia in malaria and sickle cell disease","volume":"95","author":"Gordeuk","year":"2020","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-018-2266-9","article-title":"Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated plasmodium falciparum and plasmodium vivax infections in the Republic of the Sudan","volume":"17","author":"Hamid","year":"2018","journal-title":"Malaria Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0215","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-018-06447-z","article-title":"Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator","volume":"9","author":"Hwang","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0220","author":"Hygiene, L. S. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0225","author":"Hygiene, L. S. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0230","author":"Hygiene, L. S. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0235","author":"InfaCare Pharmaceuticals Corporation, A. M. C"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0240","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/01.RES.0000083489.83704.76","article-title":"Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes","volume":"93","author":"Jain","year":"2003","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0245","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.CIR.0000112605.43318.CA","article-title":"Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase","volume":"109","author":"Jain","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0250","first-page":"1","article-title":"Can vitamin D and L-cysteine co-supplementation reduce 25(OH)-vitamin D deficiency and the mortality associated with COVID-19 in African Americans?","author":"Jain","year":"2020","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2020.10.002","article-title":"The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19","volume":"161","author":"Jain","year":"2020","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107788_bb5010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.siny.2009.10.007","article-title":"Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment","volume":"15","author":"Kaplan","year":"2010","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1016\/j.pharmthera.2020.107788_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034079","article-title":"Prevalence of and mothers\u2019 knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study","volume":"10","author":"Kasemy","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0265","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12936-018-2510-3","article-title":"Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia","volume":"17","author":"Kiessling","year":"2018","journal-title":"Malaria Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0270","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.120.14772","article-title":"CRISPR-mediated single nucleotide polymorphism Modeling in rats reveals insight into reduced cardiovascular risk associated with Mediterranean G6PD variant","volume":"76","author":"Kitagawa","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0275","author":"Kline"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0280","first-page":"15","article-title":"Evaluating of beta-carotene role in ameliorating of favism-induced disturbances in blood and testis","author":"Koriem","year":"2018","journal-title":"Journal of Complementary and Integrative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/nutrit\/nuy053","article-title":"Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency","volume":"77","author":"La Vieille","year":"2019","journal-title":"Nutrition Reviews"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0290","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00277-017-2945-6","article-title":"Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis","volume":"96","author":"Lai","year":"2017","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40064-015-0816-y","article-title":"Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: Case report and review of the literature","volume":"4","author":"Lee","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001091","article-title":"Association of G6PD variants with hemoglobin A1c and impact on diabetes diagnosis in east Asian individuals","volume":"8","author":"Leong","year":"2020","journal-title":"BMJ Open Diabetes Research & Care"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12936-017-2017-3","article-title":"Methods for the field evaluation of quantitative G6PD diagnostics: a review","volume":"16","author":"Ley","year":"2017","journal-title":"Malaria Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002992","article-title":"Performance of the access bio\/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis","volume":"16","author":"Ley","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1061","article-title":"Evidence of positively selected G6PD A- allele reduces risk of plasmodium falciparum infection in African population on Bioko Island","volume":"8","author":"Liang","year":"2020","journal-title":"Molecular Genetics & Genomic Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0320","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.gene.2018.07.068","article-title":"The gene spectrum of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Guangdong province, China","volume":"678","author":"Lin","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0325","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus Primaquine to prevent relapse of plasmodium vivax malaria","volume":"380","author":"Llanos-Cuentas","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107788_bb8000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046424","article-title":"Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria","volume":"7","author":"Lopera-Mesa","year":"2012","journal-title":"PLoS One."},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107788_bb6000","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/infdis\/jit082","article-title":"Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity","volume":"207","author":"Lopera-Mesa","year":"2013","journal-title":"J Infect Dis."},{"key":"10.1016\/j.pharmthera.2020.107788_bb0330","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/S2352-3026(15)00043-5","article-title":"Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study","volume":"2","author":"Lopera-Mesa","year":"2015","journal-title":"The Lancet Haematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2015.11.006","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"30","author":"Luzzatto","year":"2016","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0340","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164","author":"Luzzatto","year":"2014","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209204","article-title":"Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children","volume":"14","author":"May","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0350","doi-asserted-by":"crossref","first-page":"45963","DOI":"10.1038\/srep45963","article-title":"Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis","volume":"7","author":"Mbanefo","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0355","author":"Mednax Center for Research, E., Quality, & Safety"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0360","first-page":"98","article-title":"Glucose-6-phosphate dehydrogenase deficiency unveiled by diabetic ketoacidosis: A dual dilemma","volume":"65","author":"Mehta","year":"2017","journal-title":"The Journal of the Association of Physicians of India"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107788_bb7000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054481","article-title":"A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria","volume":"8","author":"Mita-Mendoza","year":"2013","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107788_bb5015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.pharmthera.2020.107788_bb0365","author":"Oxford, U. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0370","author":"Oxford, U. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","article-title":"Evaluation of a novel quantitative test for Glucose-6-phosphate dehydrogenase deficiency: Bringing quantitative testing for Glucose-6-phosphate dehydrogenase deficiency closer to the patient","volume":"100","author":"Pal","year":"2019","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107788_bb0380","first-page":"213","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) deficiency is linked with cardiovascular disease","volume":"100","author":"Parsanathan","year":"2020","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226927","article-title":"Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection","volume":"14","author":"Pengboon","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0390","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/0284186X.2019.1616815","article-title":"Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin","volume":"58","author":"Pes","year":"2019","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0395","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2019.01.027","article-title":"Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study","volume":"282","author":"Pes","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0400","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis","volume":"17","author":"Pfeffer","year":"2020","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0405","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00555491","article-title":"X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus","volume":"26","author":"Pretsch","year":"1988","journal-title":"Biochemical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0410","series-title":"Malaria. Centers for disease control and prevention","author":"Prevention, C. F. D. C. A","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0415","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cmdc.201900341","article-title":"Small-molecule activators of Glucose-6-phosphate dehydrogenase (G6PD) bridging the dimer Interface","volume":"14","author":"Raub","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006230","article-title":"Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries","volume":"12","author":"Recht","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0425","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tracli.2017.05.013","article-title":"Drug-induced hemolytic anemia: Pharmacological aspects","volume":"24","author":"Renard","year":"2017","journal-title":"Transfusion Clinique et Biologique"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0430","author":"Research"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0435","author":"Research, W. R. A. I. O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0440","series-title":"Glucose 6 phosphate dehydrogenase (G6PD) deficiency","author":"Richardson","year":"2020"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116143","article-title":"Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia","volume":"9","author":"Roca-Feltrer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0450","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1073\/pnas.1310402110","article-title":"Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity","volume":"110","author":"Rochford","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107788_bb0455","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.16366","article-title":"Laboratory diagnosis of G6PD deficiency. A british society for haematology guideline","volume":"189","author":"Roper","year":"2020","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0460","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","article-title":"Hemolytic potential of Tafenoquine in female volunteers heterozygous for Glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-Normal volunteers","volume":"97","author":"Rueangweerayut","year":"2017","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0465","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1475-2875-12-112","article-title":"Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report","volume":"12","author":"von Seidlein","year":"2013","journal-title":"Malaria Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0470","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bmj.288.6412.179","article-title":"Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency","volume":"288","author":"Shalev","year":"1984","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0475","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4103\/ijccm.IJCCM_260_18","article-title":"Hepatitis A virus-induced severe Hemolysis complicated by severe Glucose-6-phosphate dehydrogenase deficiency","volume":"22","author":"Sharma","year":"2018","journal-title":"Indian Journal of Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2019.04.080","article-title":"A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India","volume":"707","author":"Shivwanshi","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0485","author":"Southern Medical University, C"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0490","author":"Thessaly"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0495","author":"Thessaly"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.14503\/THIJ-16-6052","article-title":"Glucose-6-phosphate dehydrogenase deficiency is associated with cardiovascular disease in U.S. military Centers","volume":"45","author":"Thomas","year":"2018","journal-title":"Texas Heart Institute Journal"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0505","author":"University of California, S. F"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0510","author":"University of Mississippi, O"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0515","first-page":"64","article-title":"Significant efficacy of a single low dose of primaquine compared to stand-alone artemisinin combination therapy in reducing gametocyte carriage in cambodian patients with uncomplicated multidrug-resistant Plasmodium falciparum Malaria","author":"Vantaux","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0520","author":"Kline"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0525","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1542\/peds.2009-0460","article-title":"Complex multifactorial nature of significant hyperbilirubinemia in neonates","volume":"124","author":"Watchko","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0530","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23061","article-title":"Modelling primaquine-induced haemolysis in G6PD deficiency","volume":"6","author":"Watson","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0535","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43154","article-title":"Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria","volume":"8","author":"Watson","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107788_bb0540","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1039\/C9AN02219H","article-title":"A paper-based biosensor for visual detection of glucose-6-phosphate dehydrogenase from whole blood","volume":"145","author":"White","year":"2020","journal-title":"Analyst."},{"key":"10.1016\/j.pharmthera.2020.107788_bb0545","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.3390\/v7122966","article-title":"Glucose-6-phosphate dehydrogenase enhances antiviral response through downregulation of NADPH sensor HSCARG and upregulation of NF-kappaB Signaling","volume":"7","author":"Wu","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0550","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1086\/528377","article-title":"Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection","volume":"197","author":"Wu","year":"2008","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0555","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11060-018-2911-8","article-title":"G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity","volume":"139","author":"Yang","year":"2018","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091055","article-title":"The redox role of G6PD in cell growth, cell death, and cancer","volume":"8","author":"Yang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0565","doi-asserted-by":"crossref","first-page":"101363","DOI":"10.1016\/j.redox.2019.101363","article-title":"Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX\/p38 MAPK\/AP-1 redox signaling","volume":"28","author":"Yen","year":"2020","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0570","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/tropej\/fmaa003","article-title":"Evaluation of the diagnostic accuracy of the CareStart Glucose-6-phosphate dehydrogenase deficiency rapid diagnostic test among Chinese Newborns","volume":"66","author":"Yu","year":"2020","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0575","doi-asserted-by":"crossref","first-page":"8034672","DOI":"10.1155\/2020\/8034672","article-title":"Ex vivo study of Laban\u2019s role in decreasing Hemolysis crisis in G6PD-deficient patients","volume":"2020","author":"Zam","year":"2020","journal-title":"Journal of Nutrition and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/PHMT.S202080","article-title":"Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality","volume":"10","author":"Zekavat","year":"2019","journal-title":"Pediatric Health, Medicine and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0585","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4269\/ajtmh.12-0682","article-title":"An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines","volume":"88","author":"Zhang","year":"2013","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.pharmthera.2020.107788_bb0590","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1038\/s41598-019-40354-7","article-title":"The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females","volume":"9","author":"Zhao","year":"2019","journal-title":"Scientific Reports"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820303193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820303193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:14:26Z","timestamp":1759011266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820303193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":124,"alternative-id":["S0163725820303193"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107788","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107788"}}